$AVD
AMERICAN VANGUARD CORP

2014 Q4 Form 10-Q Financial Statement

#000119312514391725 Filed on October 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2014 Q2
Revenue $77.59M $71.64M $68.31M
YoY Change 2.74% -26.3% -21.26%
Cost Of Revenue $46.40M $43.34M $42.25M
YoY Change 7.41% -19.8% -5.46%
Gross Profit $31.24M $28.29M $26.06M
YoY Change -3.41% -34.44% -38.05%
Gross Profit Margin 40.26% 39.5% 38.15%
Selling, General & Admin $24.60M $21.50M $20.30M
YoY Change 2.93% -6.11% -15.77%
% of Gross Profit 78.75% 75.99% 77.9%
Research & Development $6.200M $5.200M $5.000M
YoY Change -10.14% 1.96% -1.96%
% of Gross Profit 19.85% 18.38% 19.19%
Depreciation & Amortization $4.330M $4.000M $4.270M
YoY Change 17.98% 7.53% 13.56%
% of Gross Profit 13.86% 14.14% 16.39%
Operating Expenses $30.80M $27.37M $25.34M
YoY Change 0.0% -2.35% -13.14%
Operating Profit $438.0K $926.0K $723.0K
YoY Change -71.58% -93.88% -94.39%
Interest Expense -$800.0K $804.0K $857.0K
YoY Change 100.0% 73.28% 22.25%
% of Operating Profit -182.65% 86.83% 118.53%
Other Income/Expense, Net
YoY Change
Pretax Income -$400.0K $147.0K -$121.0K
YoY Change -136.36% -99.0% -100.99%
Income Tax -$1.300M $0.00 -$160.0K
% Of Pretax Income 0.0%
Net Earnings $1.805M $732.0K $145.0K
YoY Change 549.28% -91.75% -98.27%
Net Earnings / Revenue 2.33% 1.02% 0.21%
Basic Earnings Per Share $0.06 $0.03 $0.01
Diluted Earnings Per Share $0.06 $0.03 $0.01
COMMON SHARES
Basic Shares Outstanding 29.11M shares 28.47M shares 28.41M shares
Diluted Shares Outstanding 28.80M shares 28.80M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2014 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.900M $5.000M $4.200M
YoY Change -26.87% -59.35% -87.04%
Cash & Equivalents $4.885M $5.045M $4.189M
Short-Term Investments
Other Short-Term Assets $22.10M $20.60M $20.50M
YoY Change 23.46% 19.08% 12.02%
Inventory $165.6M $171.5M $175.2M
Prepaid Expenses
Receivables $86.03M $89.29M $73.24M
Other Receivables $2.396M $2.660M $13.00M
Total Short-Term Assets $287.0M $291.5M $286.2M
YoY Change 15.05% 8.55% 15.97%
LONG-TERM ASSETS
Property, Plant & Equipment $50.03M $51.21M $51.62M
YoY Change -4.65% -0.83% 3.6%
Goodwill
YoY Change
Intangibles $102.2M $103.9M
YoY Change -5.94% -5.79%
Long-Term Investments $3.172M $3.022M $2.561M
YoY Change 17.44% -8.45%
Other Assets $35.04M $37.04M $37.75M
YoY Change -8.91% 7.14% 24.29%
Total Long-Term Assets $185.3M $190.4M $193.2M
YoY Change -6.4% -2.26% 1.46%
TOTAL ASSETS
Total Short-Term Assets $287.0M $291.5M $286.2M
Total Long-Term Assets $185.3M $190.4M $193.2M
Total Assets $472.3M $482.0M $479.4M
YoY Change 5.56% 4.01% 9.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.41M $17.94M $23.90M
YoY Change -49.85% -45.26% -0.22%
Accrued Expenses $52.55M $72.79M $74.36M
YoY Change -2.02% -23.96% -15.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $71.00K $71.00K $70.00K
YoY Change 2.9% 0.0% 0.0%
Total Short-Term Liabilities $81.25M $100.6M $107.3M
YoY Change -26.47% -29.43% -12.87%
LONG-TERM LIABILITIES
Long-Term Debt $98.61M $95.07M $86.09M
YoY Change 90.81% 144.44% 110.43%
Other Long-Term Liabilities $3.309M $3.380M $4.000M
YoY Change -20.13% -13.33% -6.98%
Total Long-Term Liabilities $101.9M $98.45M $86.09M
YoY Change 82.58% 153.13% 110.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.25M $100.6M $107.3M
Total Long-Term Liabilities $101.9M $98.45M $86.09M
Total Liabilities $211.3M $222.1M $220.4M
YoY Change 11.43% 8.55% 17.53%
SHAREHOLDERS EQUITY
Retained Earnings $202.5M $201.3M $201.9M
YoY Change 0.01% -1.16% 2.95%
Common Stock $69.39M $3.156M $3.153M
YoY Change 2131.84% 1.81% 1.74%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.269M $8.269M $8.269M
YoY Change 22.72% 72.13% 72.13%
Treasury Stock Shares 2.451M shares 2.451M shares 2.451M shares
Shareholders Equity $261.6M $260.2M $259.6M
YoY Change
Total Liabilities & Shareholders Equity $472.3M $482.0M $479.4M
YoY Change 5.56% 4.01% 9.65%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2014 Q2
OPERATING ACTIVITIES
Net Income $1.805M $732.0K $145.0K
YoY Change 549.28% -91.75% -98.27%
Depreciation, Depletion And Amortization $4.330M $4.000M $4.270M
YoY Change 17.98% 7.53% 13.56%
Cash From Operating Activities -$260.0K -$4.800M $12.85M
YoY Change -98.06% -62.65% -66.35%
INVESTING ACTIVITIES
Capital Expenditures -$1.230M -$2.000M -$2.130M
YoY Change -58.59% -49.11% -46.21%
Acquisitions
YoY Change
Other Investing Activities -$500.0K $0.00
YoY Change
Cash From Investing Activities -$1.730M -$2.000M -$2.130M
YoY Change -41.75% -49.11% -46.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.680M 8.070M -14.99M
YoY Change -73.47% -352.98% 31.72%
NET CHANGE
Cash From Operating Activities -260.0K -4.800M 12.85M
Cash From Investing Activities -1.730M -2.000M -2.130M
Cash From Financing Activities 2.680M 8.070M -14.99M
Net Change In Cash 690.0K 1.270M -4.270M
YoY Change -110.99% -106.36% -118.7%
FREE CASH FLOW
Cash From Operating Activities -$260.0K -$4.800M $12.85M
Capital Expenditures -$1.230M -$2.000M -$2.130M
Free Cash Flow $970.0K -$2.800M $14.98M
YoY Change -109.29% -68.61% -64.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.2927 pure
CY2013Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.0339 pure
CY2013Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.17
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12325000
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.80
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.74
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
478379 shares
CY2014Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
259060000
CY2014Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-861000
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.81
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.77
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
460879 shares
CY2014Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
259091000
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-624000
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31554063 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2014Q3 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.0339 pure
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.81
CY2014Q3 us-gaap Number Of Interest Rate Derivatives Held
NumberOfInterestRateDerivativesHeld
1 Contract
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.81
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
2450634 shares
CY2014Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.1928 pure
CY2014Q3 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.15
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
459879 shares
CY2014Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
259897000
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1397000
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
81002000
CY2014Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
268476000
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
100624000
CY2014Q3 us-gaap Derivative Liabilities
DerivativeLiabilities
138000
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
3156000
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-970000
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
17935000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
260207000
CY2014Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3380000
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
201252000
CY2014Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
71000
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
23002000
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
72790000
CY2014Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
95073000
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
481976000
CY2014Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
65038000
CY2014Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
7412000
CY2014Q3 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1019000
CY2014Q3 us-gaap Minority Interest
MinorityInterest
-310000
CY2014Q3 us-gaap Liabilities
Liabilities
222079000
CY2014Q3 us-gaap Long Term Debt
LongTermDebt
95144000
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
434000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5045000
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51214000
CY2014Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
91947000
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
14086000
CY2014Q3 us-gaap Equity Method Investments
EquityMethodInvestments
3022000
CY2014Q3 us-gaap Equity Method Investment Quoted Market Value
EquityMethodInvestmentQuotedMarketValue
6321000
CY2014Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
148927000
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
132216000
CY2014Q3 us-gaap Assets
Assets
481976000
CY2014Q3 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6521000
CY2014Q3 us-gaap Inventory Net
InventoryNet
171520000
CY2014Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
22593000
CY2014Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2660000
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
89287000
CY2014Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2414000
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
102192000
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37037000
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
8269000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
291533000
CY2014Q3 avd Derivative Liabilities Gross Amounts Offset In Statement Of Financial Position
DerivativeLiabilitiesGrossAmountsOffsetInStatementOfFinancialPosition
CY2014Q3 avd Derivative Liabilities Net Of Gross Amounts Not Offset In Statement Of Financial Position
DerivativeLiabilitiesNetOfGrossAmountsNotOffsetInStatementOfFinancialPosition
138000
CY2014Q3 avd Gross Amounts Not Offset Against Collateral
GrossAmountsNotOffsetAgainstCollateral
CY2014Q3 avd Derivative Liability Fair Value Gross Liability
DerivativeLiabilityFairValueGrossLiability
138000
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29109085 shares
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38476000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31092782 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.76
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
7.70
CY2013Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
2380634 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.1
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
400000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2013Q4 us-gaap Long Term Debt
LongTermDebt
51745000
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
561029 shares
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257795000
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2132000
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78951000
CY2013Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
264691000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
110499000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
3109000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1048000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
40702000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
202470000
CY2013Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
69000
CY2013Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
23330000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
53630000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
257953000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4143000
CY2013Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
51676000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
447443000
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
60160000
CY2013Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
10178000
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3788000
CY2013Q4 us-gaap Minority Interest
MinorityInterest
-158000
CY2013Q4 us-gaap Liabilities
Liabilities
189648000
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
392000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6680000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52468000
CY2013Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
74952000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11435000
CY2013Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
126872000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
131419000
CY2013Q4 us-gaap Assets
Assets
447443000
CY2013Q4 us-gaap Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
6521000
CY2013Q4 us-gaap Inventory Net
InventoryNet
139830000
CY2013Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12958000
CY2013Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
892000
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74060000
CY2013Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
10088000
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
107007000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38462000
CY2013Q4 us-gaap Treasury Stock Value
TreasuryStockValue
6738000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
249506000
CY2013Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.18
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.35 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
595000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
7200000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28890000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.21
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28295000 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-195000
us-gaap Gross Profit
GrossProfit
139006000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
280297000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
46000000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3687000
us-gaap Payments Of Dividends
PaymentsOfDividends
3390000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
34304000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
57000
us-gaap Sales Revenue Net
SalesRevenueNet
305499000
us-gaap Profit Loss
ProfitLoss
33830000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14564000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
39221000
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
-1000
us-gaap Operating Income Loss
OperatingIncomeLoss
54183000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
34461000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
12290000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52716000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-59000
us-gaap Net Income Loss
NetIncomeLoss
34171000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-543000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1415000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
245000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
520000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
485000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-386000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11183000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-151000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-20034000
us-gaap Interest Expense
InterestExpense
1712000
us-gaap Operating Expenses
OperatingExpenses
84823000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
57000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26000000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
2895000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18500000
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-6154000
us-gaap Cost Of Revenue
CostOfRevenue
166493000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-17223000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
929000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
130000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15977000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
412000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-341000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
2976000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
38750000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
64088000
avd Cash Dividend Paid
CashDividendPaid
4805000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
25202000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
34216000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
AMERICAN VANGUARD CORP
dei Trading Symbol
TradingSymbol
AVD
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
us-gaap Derivative Inception Dates
DerivativeInceptionDates
2011-03-30
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
466000 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-33836000
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28888000 shares
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimate Of Time To Transfer1
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimateOfTimeToTransfer1
P12M
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
dei Entity Central Index Key
EntityCentralIndexKey
0000005981
us-gaap Derivative Maturity Dates
DerivativeMaturityDates
2014-12-31
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-348000
us-gaap Gross Profit
GrossProfit
83258000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
195254000
us-gaap Payments Of Dividends
PaymentsOfDividends
4251000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
16995000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
263000
us-gaap Sales Revenue Net
SalesRevenueNet
221043000
us-gaap Profit Loss
ProfitLoss
2584000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5237000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31690000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6183 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 Product
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28422000 shares
us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
us-gaap Operating Income Loss
OperatingIncomeLoss
6309000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3114000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
5947000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
328000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
4073000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1531000
us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-32000
us-gaap Net Income Loss
NetIncomeLoss
3036000
us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-459000
us-gaap Derivative Instruments Gain Loss Reclassification From Accumulated Oci To Income Estimated Net Amount To Be Transferred
DerivativeInstrumentsGainLossReclassificationFromAccumulatedOCIToIncomeEstimatedNetAmountToBeTransferred
31125000
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1371000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
56000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-7937000
us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
426000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-633000
us-gaap Gain Loss On Sale Of Equity Investments
GainLossOnSaleOfEquityInvestments
954000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11996000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-328000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2769000
us-gaap Interest Expense
InterestExpense
2292000
us-gaap Operating Expenses
OperatingExpenses
76949000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
263000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1307000
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
3046000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
856000
us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
300000
us-gaap Cost Of Revenue
CostOfRevenue
137785000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
38476000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1616000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
249000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5947000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22341000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-452000
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
4332000
us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
43450000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15964000
avd Cash Dividend Paid
CashDividendPaid
4254000
avd Sales Of Non Crop Products
SalesOfNonCropProducts
25789000
avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
3217000
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2014Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
82650 shares
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
51000
CY2014Q1 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
393000
CY2014Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
625000
CY2014Q1 us-gaap Profit Loss
ProfitLoss
2005000
CY2014Q1 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
28000
CY2014Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
768000
CY2014Q1 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
136000
CY2014Q1 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
235000
CY2014Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1531000
CY2014Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1417000
CY2014Q1 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-159000
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2014Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
17500 shares
CY2014Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
92000
CY2014Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
178000
CY2014Q2 us-gaap Profit Loss
ProfitLoss
-29000
CY2014Q2 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
84000
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1038000
CY2014Q2 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
145000
CY2014Q2 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
27000
CY2014Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1420000
CY2014Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-153000
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.31
CY2013Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
567000 shares
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28889000 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2013Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28322000 shares
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-126000
CY2013Q3 us-gaap Gross Profit
GrossProfit
43159000
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
87608000
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
97201000
CY2013Q3 us-gaap Profit Loss
ProfitLoss
8745000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
15134000
CY2013Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8877000
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
14690000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-43000
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
8870000
CY2013Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-176000
CY2013Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
20000
CY2013Q3 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
133000
CY2013Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-386000
CY2013Q3 us-gaap Interest Expense
InterestExpense
464000
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
28025000
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5559000
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
54042000
CY2013Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-125000
CY2013Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
9593000
CY2013Q3 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
9131000
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2014Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.50
CY2014Q3 us-gaap Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
300000
CY2014Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
331000 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28797000 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.05
CY2014Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1207 shares
CY2014Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1000 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28466000 shares
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-491000
CY2014Q3 us-gaap Gross Profit
GrossProfit
28293000
CY2014Q3 us-gaap Stock Issued During Period Value Employee Stock Ownership Plan
StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan
413000
CY2014Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7000
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
64700000
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
71635000
CY2014Q3 us-gaap Profit Loss
ProfitLoss
608000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Recognized In Income Ineffective Portion And Amount Excluded From Effectiveness Testing Net
DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet
0
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment
5150000
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1624000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
386000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
845000
CY2014Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Before Tax
OtherComprehensiveIncomeLossBeforeReclassificationsBeforeTax
-491000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Recognized In Other Comprehensive Income Effective Portion Net
DerivativeInstrumentsGainLossRecognizedInOtherComprehensiveIncomeEffectivePortionNet
-1000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
732000
CY2014Q3 us-gaap Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net
DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet
-146000
CY2014Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1240000
CY2014Q3 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
25000
CY2014Q3 us-gaap Increase Decrease In Fair Value Of Interest Rate Fair Value Hedging Instruments1
IncreaseDecreaseInFairValueOfInterestRateFairValueHedgingInstruments1
145000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-237000
CY2014Q3 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2014Q3 us-gaap Interest Expense
InterestExpense
804000
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
26669000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
43342000
CY2014Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
1417000
CY2014Q3 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Before Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax
-145000
CY2014Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-124000
CY2014Q3 avd Sales Of Non Crop Products
SalesOfNonCropProducts
6935000
CY2014Q3 avd Income Loss Before Equity Method Investments
IncomeLossBeforeEquityMethodInvestments
845000

Files In Submission

Name View Source Status
0001193125-14-391725-index-headers.html Edgar Link pending
0001193125-14-391725-index.html Edgar Link pending
0001193125-14-391725.txt Edgar Link pending
0001193125-14-391725-xbrl.zip Edgar Link pending
avd-20140930.xml Edgar Link completed
avd-20140930.xsd Edgar Link pending
avd-20140930_cal.xml Edgar Link unprocessable
avd-20140930_def.xml Edgar Link unprocessable
avd-20140930_lab.xml Edgar Link unprocessable
avd-20140930_pre.xml Edgar Link unprocessable
d797424d10q.htm Edgar Link pending
d797424dex311.htm Edgar Link pending
d797424dex312.htm Edgar Link pending
d797424dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending